Skip to main content
Veterinary Medicines

Dermanolon 1.77 mg/ml + 17.7 mg/ml cutaneous spray, solution for dogs and cats

Authorised
  • Triamcinolone acetonide
  • Salicylic acid

Product identification

Medicine name:
Dermanolon 1.77 mg/ml + 17.7 mg/ml cutaneous spray, solution for dogs and cats
Active substance:
  • Triamcinolone acetonide
  • Salicylic acid
Target species:
  • Dog
  • Cat
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Triamcinolone acetonide
    2.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Salicylic acid
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Cutaneous spray, solution
Withdrawal period by route of administration:
  • Cutaneous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QD07XB02
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Carton containing one 75 ml white, high density polyethylene container with spray pump and a styrene acrylonitrile polymer cap.
  • Carton containing one 50 ml white, high density polyethylene container with spray pump and a styrene acrylonitrile polymer cap.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Le Vet. Beheer B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Produlab Pharma B.V.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10475/026/001
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0205/001
Concerned member states:
  • Austria
  • Belgium
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."